维普期刊资源整合服务平台（V6.5）

94篇 您的检索式：作者名="Spigel D"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Treatment of metastatic renal cell carcinoma with a combination of bevacizu-nab and erlotinib显示文摘	Hainsworth J D Sosman J A Spigel D R	2005	J Clin Oncol2005，23，31：	1
2	ASCEND-2: A single-arm, open-label, multicenter phase II study of ceritinib in adult patients (pts) with ALK- rearranged (ALK+) non-small cell lung cancer (NSCLC) previously treated with chemotherapy and crizotinib (CRZ)显示文摘	Mok T Spigel D Felip E	2015	J Clin Oncol2015，33，：	1
3	Phase Ⅱ trial of ixabepilone and carboplatin with or without bevacizumab in patients with previously untreated advanced non-small cell lung cancer显示文摘	Shipley D Spigel DR Burris HA	2010	J Clin Oneol(Meeting Abstracts)2010，28，15：	1
4	First-line gefitinib inpa- tientswith advanced non-small-cell lung cancer harboring somatic EGFR mutations 显示文摘	Sequist LV Martins RG Spigel D	2008	J ClinOncol2008，26，15：	1
5	Phase II trial of bevacizumab and everolimus in patients with advanced renal cell carcinoma显示文摘	Hainsworth J D Spigel D R Burris H R	2010	J Clin Oncol2010，28，13：	1
6	First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations显示文摘	Sequist L V Martins R G Spigel D	2008	J Clin Oncol2008，26，15：	1
7	Phase Ⅰ/Ⅱ trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction显示文摘	Spigel D R Greco F A Meluch A A	2010	J Clin Oncol2010，28，13：	1
8	Rationale for chemotherapy,immunother- apy,and checkpoint blockade in SCLC:beyond traditional treatment approaches显示文摘	Spigel D R Soeinski M A	2013	J Thorac Oncol2013，8，5：	1
9	Chemotherapy in metastatic and locally advanced non-small cell lung cancer显示文摘	SPIGEL D R GRECO F A	2003	Semin Surg Oncol2003，21，2：	1
10	Rituximab with short duration chemotherapy followed by ^90Y- Ibritumomab tiuxetana as first - line treatment for patients with follicular lymphoma: update of a Minnie Pearl Cancer Research Network phase II trial显示文摘	Shipley D Greco F Spigel R	2005	J Clin Oncol2005，23，16：	1
11	Weekly docetaxel versus docetaxel/gemcitabine in elderly/poor performance status (PS) patients (pts) with stage ⅢB/Ⅳ non-small cell lung cancer (NSCLC):Randomized phase Ⅲ trial of the minnie pearl cancer research network显示文摘	GRECO F A SPIGEL D R BURRIS H A	2007	J Clin Oncol2007，，：	1
12	Treatment of metastatic renal cell carcinoma with a combination of bevacizumab and Erlotinib显示文摘	Hainsworth J D Sosman J A Spigel D R	2005	J Clin Oncol2005，23，31：	1
13	Phase II study of maintenance sunitinih following irinoteean and earboplatin as first -line treatment for patients with ex- tensive- stage small- cell lung cancer 显示文摘	Spigel D R Greeo F A Rubin M S	2012	Lung Cancer2012，77，2：	1
14	Phase II trial of irinotecan, carboplatin, and bevacizumab in the treatment of patients with extensive-stage small-cell lung cancer 显示文摘	Spigel D R Greco F A Zubkus J D	2009	J Thorac Oncol2009，4，12：	1
15	Randomized phase II study of bevacizumab in combination with chemotherapy in previously untreated extensive-stage small-cell lung cancer: results from the SALUTE trial显示文摘	Spigel D R Townley P M Waterhouse D M	2011	J Clin Oncol2011，29，16：	1
16	First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations 显示文摘	SEQUIST L V MARTINS R G SPIGEL D	2008	J Clin Oncol2008，26，15：	1
17	First-line ge- fitinib in patients with advanced non- small- cell lung cancer harboring somatic EGFR mutations显示文摘	SEQUIST L V MARTINS R G SPIGEL D	2008	J Clin Oncol2008，26，15：	1
18	First-line gefitinib in patients with advanced nonsmallcell lung cancer harboring somatic EGFR mutations 显示文摘	Sequist LV Martins RG Spigel D	2008	J Clin Oncol2008，26，15：	1
19	First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations显示文摘	Sequist LV Martins RG Spigel D	2008	J Clin Oncol2008，26，15：	1
20	Phase II trial of bevacizumab and erlotinib in carcinomas of un- known primary site: the Minnie Pearl Cancer Research Network显示文摘	Hainsworth J D Spigel D R Farley C	2007	J Clin Oncol2007，25，13：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示